Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALCMI-012 A Prospective Biospecimen Collection Study From Patients With EGFR Mutant Tumors

NCT03872440 is registered in ClinicalTrials.gov with Addario Lung Cancer Medical Institute as lead sponsor.

NCT NCT03872440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03872440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALCMI-012 A Prospective Biospecimen Collection Study From Patients With EGFR Mutant Tumors
Lead sponsor
Addario Lung Cancer Medical Institute
Phase
Observational
Overall status
Withdrawn
Start date
November 14, 2018
Completion date
January 6, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer